Latest Cord blood Stories
A study comparing whether endothelial colony-forming cells (ECFCs) derived from human placenta or those derived from human umbilical cord blood are more proliferative and better for forming new blood vessels has found that ECFCs derived from human placenta are more vasculogenic. The study, carried out by researchers at the Indiana School of Medicine, is published in a recent issue of Cell Medicine and is freely available on-line at: http://www.ingentaconnect.com/content/cog/cm....
Management Predicts that Cord Blood Industry Stalwarts ViaCord and CBR (aka "Cord Blood Registry") Will Soon Follow Suit New York, NY (PRWEB) July 16, 2012 After KKR invested $65 million in China Cord Blood in April, investors again began to take notice of this small but rapidly growing industry. One cord blood banking upstart, Americord Registry, meanwhile quietly continues to gain traction and take market share from the leading cord blood companies. While many cord blood...
Your genes determine much about you, but environment can have a strong influence on your genes even before birth, with consequences that can last a lifetime. In a study published online in Genome Research, researchers have for the first time shown that the environment experienced in the womb defines the newborn epigenetic profile, the chemical modifications to DNA we are born with, that could have implications for disease risk later in life. Epigenetic tagging of genes by a chemical...
LAS VEGAS, July 13, 2012 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC-BB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that it has filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange Commission (www.sec.gov). As detailed in its July 9, 2012 press release, the successful negotiation...
NEW YORK, July 9, 2012 /PRNewswire/ -- In a recent interview for Fox News, Martin Smithmyer, CEO of Americord Registry, one of the industry's leading cord blood banking companies, said, "Although [Americord] does not pay doctors for making referrals, this is a common practice among some of our competitors, including at least 3 of the top 6 cord blood banks." The Obama administration, in January 2012, made it clear that under the new health care law it will require certain...
HONG KONG, July 5, 2012 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company repurchased an aggregate of 2,191,412 ordinary shares for a total consideration of approximately $6.2 million since August 2011. The total number of shares repurchased represents approximately 41% of the total $15 million authorized under the existing buyback program,...
TAMPA, Fla., July 3, 2012 /PRNewswire/ -- On behalf of Saneron CCEL Therapeutics, Inc., President and COO, Nicole Kuzmin-Nichols, MBA, expressed strong support today for the Cryo-Cell International, Inc. (OTCQB: CCEL) current executive management in response to a proxy bid by a former Board member. Cryo-Cell is a major shareholder in Saneron, a Tampa based biotechnology research and development company that was spun out from the University of South Florida to develop cellular...
RANCHO CORDOVA, Calif., July 2, 2012 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, said today that Asahi Kasei Medical Co., Ltd., has exercised its option to purchase the Company's CryoSeal Fibrin Sealant System wound care product line for $2 million in cash, effective June 30, 2012. Payment is due during the Company's first fiscal quarter of 2013. This transaction is...
LAS VEGAS, June 25, 2012 /PRNewswire/ -- Cord Blood America, Inc. (OTC BB: CBAI) is pleased to announce it has finalized an Agreement with the individuals from whom CBAI acquired its majority interest in BioCordcell (BioCells) Argentina, S.A. regarding the 2011 earn-out, previously in dispute as disclosed in the Company's most recent 10Q and 10K filings. The terms of the Agreement limit the cash payout to the sellers during 2012 to $60,000. Additionally, the Agreement provides...
ST. PAUL and DULUTH, Minn., June 21, 2012 /PRNewswire-USNewswire/ -- Memorial Blood Centers (MBC), among Minnesota's oldest and largest nonprofit community blood centers, is calling upon all area blood donors to help replenish the blood supply after severe weather and flooding in northern Minnesota closed three of its blood donor centers (Duluth, Superior, and Hibbing) and cancelled or postponed blood drives in the Northland region on Wednesday. Northland blood donors contribute...
